Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab

NCT04681677 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped unspecified business decision

Conditions

Glioblastoma
Recurrent Glioblastoma
GBM
Recurrent GBM

Interventions

RADIATION: Radiation: Intra-operative Radiation Therapy - IORT
DRUG: Bevacizumab

Sponsor

Xoft, Inc.

Collaborators

[object Object]